Adenomatous polyposis coli interacts with flap endonuclease 1 to block its nuclear entry and function

Aruna S. Jaiswal; Melissa L. Armas; Tadahide Izumi; Phyllis R. Strauss; Satya Narayan

doi:10.1593/neo.12680

Adenomatous polyposis coli interacts with flap endonuclease 1 to block its nuclear entry and function

Aruna S. Jaiswal, Melissa L. Armas, Tadahide Izumi, Phyllis R. Strauss, Satya Narayan

Toxicology and Cancer Biology

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

In previous studies, we found that adenomatous polyposis coli (APC) blocks the base excision repair (BER) pathway by interacting with 5′-flap endonuclease 1 (Fen1). In this study, we identify the molecular features that contribute to the formation and/or stabilization of the APC/Fen1 complex that determines the extent of BER inhibition, and the subsequent accumulation of DNA damage creates mutagenic lesions leading to transformation susceptibility. We show here that APC binds to the nuclear localization sequence of Fen1 (Lys³⁶⁵Lys³⁶⁶Lys³⁶⁷), which prevents entry of Fen1 into the nucleus and participation in Pol-β-directed long-patch BER. We also show that levels of the APC/Fen1 complex are higher in breast tumors than in the surrounding normal tissues. These studies demonstrate a novel role for APC in the suppression of Fen1 activity in the BER pathway and a new biomarker profile to be explored to identify individuals who may be susceptible to the development of mammary and other tumors.

Original language	English
Pages (from-to)	495-508
Number of pages	14
Journal	Neoplasia (United States)
Volume	14
Issue number	6
DOIs	https://doi.org/10.1593/neo.12680
State	Published - Jun 2012

Bibliographical note

Funding Information:
Abbreviations: APC, adenomatous polyposis coli; DRI domain, DNA repair inhibitory domain; Fen1, flap endonuclease 1; LP-BER, long-patch base excision repair; NLS, nuclear localization signal; Pol-β, DNA polymerase β Address all correspondence to: Satya Narayan, PhD, Department of Anatomy and Cell Biology, Basic Science Bldg, Room B1-016, PO Box 100235, University of Florida, Gainesville, FL 32610. E-mail: [email protected] 1Financial support for these studies was provided by grants from the National Institutes of Health (R01-CA097031 and R01-CA100247 to S.N. and RO1-CA98664 to T.I.) and Flight Attendant Medical Research Institute, Miami, FL (CIA-072088) to S.N. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article. 2These authors equally contributed to this study. Received 12 April 2012; Revised 4 May 2012; Accepted 7 May 2012 Copyright © 2012 Neoplasia Press, Inc. All rights reserved 1522-8002/12/$25.00 DOI 10.1593/neo.12680

ASJC Scopus subject areas

Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1593/neo.12680

Cite this

@article{f4ae6d2e29e347f1b0f7ef992d392378,

title = "Adenomatous polyposis coli interacts with flap endonuclease 1 to block its nuclear entry and function",

abstract = "In previous studies, we found that adenomatous polyposis coli (APC) blocks the base excision repair (BER) pathway by interacting with 5′-flap endonuclease 1 (Fen1). In this study, we identify the molecular features that contribute to the formation and/or stabilization of the APC/Fen1 complex that determines the extent of BER inhibition, and the subsequent accumulation of DNA damage creates mutagenic lesions leading to transformation susceptibility. We show here that APC binds to the nuclear localization sequence of Fen1 (Lys365Lys366Lys367), which prevents entry of Fen1 into the nucleus and participation in Pol-β-directed long-patch BER. We also show that levels of the APC/Fen1 complex are higher in breast tumors than in the surrounding normal tissues. These studies demonstrate a novel role for APC in the suppression of Fen1 activity in the BER pathway and a new biomarker profile to be explored to identify individuals who may be susceptible to the development of mammary and other tumors.",

author = "Jaiswal, {Aruna S.} and Armas, {Melissa L.} and Tadahide Izumi and Strauss, {Phyllis R.} and Satya Narayan",

note = "Funding Information: Abbreviations: APC, adenomatous polyposis coli; DRI domain, DNA repair inhibitory domain; Fen1, flap endonuclease 1; LP-BER, long-patch base excision repair; NLS, nuclear localization signal; Pol-β, DNA polymerase β Address all correspondence to: Satya Narayan, PhD, Department of Anatomy and Cell Biology, Basic Science Bldg, Room B1-016, PO Box 100235, University of Florida, Gainesville, FL 32610. E-mail: [email protected] 1Financial support for these studies was provided by grants from the National Institutes of Health (R01-CA097031 and R01-CA100247 to S.N. and RO1-CA98664 to T.I.) and Flight Attendant Medical Research Institute, Miami, FL (CIA-072088) to S.N. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article. 2These authors equally contributed to this study. Received 12 April 2012; Revised 4 May 2012; Accepted 7 May 2012 Copyright {\textcopyright} 2012 Neoplasia Press, Inc. All rights reserved 1522-8002/12/$25.00 DOI 10.1593/neo.12680",

year = "2012",

month = jun,

doi = "10.1593/neo.12680",

language = "English",

volume = "14",

pages = "495--508",

number = "6",

}

TY - JOUR

T1 - Adenomatous polyposis coli interacts with flap endonuclease 1 to block its nuclear entry and function

AU - Jaiswal, Aruna S.

AU - Armas, Melissa L.

AU - Izumi, Tadahide

AU - Strauss, Phyllis R.

AU - Narayan, Satya

N1 - Funding Information: Abbreviations: APC, adenomatous polyposis coli; DRI domain, DNA repair inhibitory domain; Fen1, flap endonuclease 1; LP-BER, long-patch base excision repair; NLS, nuclear localization signal; Pol-β, DNA polymerase β Address all correspondence to: Satya Narayan, PhD, Department of Anatomy and Cell Biology, Basic Science Bldg, Room B1-016, PO Box 100235, University of Florida, Gainesville, FL 32610. E-mail: [email protected] 1Financial support for these studies was provided by grants from the National Institutes of Health (R01-CA097031 and R01-CA100247 to S.N. and RO1-CA98664 to T.I.) and Flight Attendant Medical Research Institute, Miami, FL (CIA-072088) to S.N. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article. 2These authors equally contributed to this study. Received 12 April 2012; Revised 4 May 2012; Accepted 7 May 2012 Copyright © 2012 Neoplasia Press, Inc. All rights reserved 1522-8002/12/$25.00 DOI 10.1593/neo.12680

PY - 2012/6

Y1 - 2012/6

N2 - In previous studies, we found that adenomatous polyposis coli (APC) blocks the base excision repair (BER) pathway by interacting with 5′-flap endonuclease 1 (Fen1). In this study, we identify the molecular features that contribute to the formation and/or stabilization of the APC/Fen1 complex that determines the extent of BER inhibition, and the subsequent accumulation of DNA damage creates mutagenic lesions leading to transformation susceptibility. We show here that APC binds to the nuclear localization sequence of Fen1 (Lys365Lys366Lys367), which prevents entry of Fen1 into the nucleus and participation in Pol-β-directed long-patch BER. We also show that levels of the APC/Fen1 complex are higher in breast tumors than in the surrounding normal tissues. These studies demonstrate a novel role for APC in the suppression of Fen1 activity in the BER pathway and a new biomarker profile to be explored to identify individuals who may be susceptible to the development of mammary and other tumors.

AB - In previous studies, we found that adenomatous polyposis coli (APC) blocks the base excision repair (BER) pathway by interacting with 5′-flap endonuclease 1 (Fen1). In this study, we identify the molecular features that contribute to the formation and/or stabilization of the APC/Fen1 complex that determines the extent of BER inhibition, and the subsequent accumulation of DNA damage creates mutagenic lesions leading to transformation susceptibility. We show here that APC binds to the nuclear localization sequence of Fen1 (Lys365Lys366Lys367), which prevents entry of Fen1 into the nucleus and participation in Pol-β-directed long-patch BER. We also show that levels of the APC/Fen1 complex are higher in breast tumors than in the surrounding normal tissues. These studies demonstrate a novel role for APC in the suppression of Fen1 activity in the BER pathway and a new biomarker profile to be explored to identify individuals who may be susceptible to the development of mammary and other tumors.

UR - http://www.scopus.com/inward/record.url?scp=84865617484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865617484&partnerID=8YFLogxK

U2 - 10.1593/neo.12680

DO - 10.1593/neo.12680

M3 - Article

C2 - 22787431

AN - SCOPUS:84865617484

SN - 1522-8002

VL - 14

SP - 495

EP - 508

JO - Neoplasia (United States)

JF - Neoplasia (United States)

IS - 6

ER -

Adenomatous polyposis coli interacts with flap endonuclease 1 to block its nuclear entry and function

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this